PARTICULATE MATTER DETECTION SENSOR AND CONTROL DEVICE OF CONTROLLING THE SAME
    1.
    发明申请
    PARTICULATE MATTER DETECTION SENSOR AND CONTROL DEVICE OF CONTROLLING THE SAME 审中-公开
    颗粒物检测传感器及其控制装置

    公开(公告)号:US20110314796A1

    公开(公告)日:2011-12-29

    申请号:US13170269

    申请日:2011-06-28

    IPC分类号: F01N3/00

    摘要: A particulate matter (PM) detection sensor is placed in an exhaust gas pipe of a diesel engine. The PM sensor element has a detection part composed of a pair of detection electrodes and a heater part. The detection electrodes and the heater part are stacked in the PM sensor element. A control circuit instructs a heater power supply to supply electric power to the heater part when the diesel engine is started to operate. The heater part heats the detection part at a predetermined temperature T1 within a range of 600° C. to 900° C. for a predetermined period S1 of time, for example, 650° C. for 20 seconds, in order to burn and completely eliminate particulate matter accumulated in the detection part. This control process avoids incorrect detection of the PM detection sensor. After this process, the control circuit executes usual control of the PM detection sensor.

    摘要翻译: 将颗粒物质(PM)检测传感器放置在柴油发动机的排气管中。 PM传感器元件具有由一对检测电极和加热器部分构成的检测部。 检测电极和加热器部分堆叠在PM传感器元件中。 当柴油发动机开始运行时,控制电路指示加热器电源向加热器部分供电。 加热器部件在600℃至900℃的范围内的预定温度T1下将检测部分加热预定时间段S1的时间,例如650℃,持续20秒,以便燃烧并完全 消除检测部件中累积的颗粒物。 该控制过程避免了PM检测传感器的错误检测。 在该处理之后,控制电路执行PM检测传感器的通常控制。

    Hollow granular medicine and its preparation
    5.
    发明授权
    Hollow granular medicine and its preparation 失效
    中空粒状药物及其制备

    公开(公告)号:US5057323A

    公开(公告)日:1991-10-15

    申请号:US367948

    申请日:1989-06-19

    IPC分类号: A61K9/00 A61K9/16

    CPC分类号: A61K9/0065 A61K9/1676

    摘要: A granular medicine with slow drug-release characteristics that is sufficiently absorbed in the intestines, in which the granular medicine has a hollow spherical structure, a drug is dispersed in the shell, which mainly consists of an enteron-soluble polymer. The method for preparing the medicine includes the steps of: (a) mixing a hydrophilic or hydrophobic drug with an enteron-soluble polymer in a mixture of an aliphatic alcohol and a chlorohydrocarbon; and (b) pouring this mixture into water or an aqueous medium, and stirring the solution to precipitate the medicine.

    摘要翻译: 具有缓慢的药物释放特性的颗粒药物在肠中充分吸收,其中颗粒药物具有中空球形结构,药物分散在壳中,其主要由肠溶性聚合物组成。 制备药物的方法包括以下步骤:(a)将亲水或疏水性药物与肠溶性聚合物混合在脂族醇和氯代烃的混合物中; 和(b)将该混合物倒入水或水性介质中,并搅拌该溶液以沉淀药物。

    Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye
    9.
    发明授权
    Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye 有权
    用于输送到眼后段的脂质体和眼后部疾病的药物组合物

    公开(公告)号:US09114070B2

    公开(公告)日:2015-08-25

    申请号:US12919807

    申请日:2009-02-26

    IPC分类号: A61K9/127 A61K9/00 A61K31/00

    摘要: The invention provides a liposome for delivery to the posterior segment of the eye, comprising (A) a phospholipid, (B) a charged substance, and/or (C) a membrane-reinforcing substance; the liposome having a rigidity that provides the liposome with cell membrane permeability, and having a mean particle diameter of 1 μm or less; and a pharmaceutical composition for a disease in the posterior segment of an eye, comprising a drug encapsulated in the liposome. The liposome is delivered to the posterior segment of the eye by instillation, and is non-cytotoxic; and the pharmaceutical composition for a disease in the posterior segment of the eye comprises the liposome.

    摘要翻译: 本发明提供一种用于输送到眼后段的脂质体,包括(A)磷脂,(B)带电物质和/或(C)膜增强物质; 所述脂质体具有赋予所述脂质体细胞膜通透性并且平均粒径为1μm以下的刚性; 和用于眼后段疾病的药物组合物,其包含包封在脂质体中的药物。 通过滴注将脂质体递送至眼后段,是非细胞毒性的; 并且眼睛后段中疾病的药物组合物包含脂质体。